期刊文献+

Taguchi正交法优化奥沙利铂长循环脂质体的制备 被引量:5

Optimization of oxaliplatin long circulated liposomes by Taguchi orthogonal design
下载PDF
导出
摘要 目的通过优化奥沙利铂(L-OHP)长循环脂质体的制备工艺,以提高其包封率(entrapment efficiency,EE%)并达到缓释效果。方法采用Taguchi正交法L9(34)(TOA),以包封率作为考察指标并采用超滤法检测包封率。考察了L-OHP脂质体的粒径、zeta电位、形态以及体外释放行为。结果药物与脂质间的比例(W/W),胆固醇与磷脂酰胆碱的比值(M/M)和超声时间是影响最大的三个因素(P<0.05)。此外,优化后的奥沙利铂脂质体经mPEG修饰后与未修饰的奥沙利铂脂质体相比较,具有更好的物理化学特性,其粒径为(204±1.1)nm,包封率高达25.40%±2.5%。修饰后的脂质体在透射电子显微镜下呈现球形结构,具有较大的内部空间,脂质体表面可见白色mPEG层状结构。经mPEG修饰的奥沙利铂脂质体相比于未修饰的脂质体,具有更低的体外释放速率,具有一定缓释能力。修饰与未修饰的脂质体以及奥沙利铂溶液均符合一级释放模型,拟合系数为0.990 2。结论经Taguchi正交法优化后的奥沙利铂长循环脂质体可作为一种新型的肿瘤靶向药物传递系统。 Objective To optimize the preparation parameters of oxaliplatin long circulated Liposomes for enhancing maximum entrapment efficiency( EE% ) exerting sustained - release property. Methods Taguchi orthogonaL arrays L9 ( 34 ) (TOA) was applied in this investigation with encapsulation efficiency as an evaluation index. The entrapment efficiency was calculated using Ultra- filtration techniques. The particle size ,zeta potential and in vitro release behavior of L- OHP lipo- somes were characterized. Results The drug to lipids ratio (W/W) , the cholesterol to phosphatidylchoLine ratio ( M/M ) and the sonication time were found to be the most influencing factors ( P 〈 0.05 ). Moreover, the optimized L - OHP mPEG - modified liposome showed better physieoehemical characteristics compared to the optimized L - OHP bare Liposomes with a smaller particle size of 204 mn and higher entrapment efficiency up to 25.4%. TEM visualization revealed spherical struc- ture with a large internal space and a white coated film surrounding the mPEG - modified liposomes. The in vitro release of L - OHP fi'om mPEG - modified liposome was found to be slower than that of bare liposomes and L - OHP solution, respec- tively. The release profile of both liposomes and solution were well described by first order model with a coefficient correla- tion of 0.990 2. Conclusion The optimized L - OHP long circulated liposomes using TOA design may be a promising car- rier for L - OHP delivery into tumors compared to the conventional bare liposome.
出处 《药学研究》 CAS 2014年第4期187-191,195,共6页 Journal of Pharmaceutical Research
基金 国家自然科学基金(No.81201182) 中央高校基本科研业务费专项基金(No.JKPZ2013006)
关键词 Taguchi正交法 mPEG修饰 脂质体 奥沙利铂 药物传递系统 Taguchi orthogonal array mPEG - modified liposome Bare liposome Oxaliplatin Drug delivery system
  • 相关文献

参考文献18

  • 1Des Guetz G,Lecaille C,Mariani P. Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX[J].Anticancer Research,2010,(10):4297-4301.
  • 2Tampellini M. Pharmacoeconomic aspects of FOLFIRI or FOLFOX regimens administered with a fully ambulatory pump compared to the day hospital setting[J].TUMORI,2010,(03):438-442.
  • 3Tashir T,Kawada Y,SakuraI Y. Antitumor activity of a new platinum complex,oxalato(trans-l-1,2-dia minocyclohexane) platinum (Ⅱ):new experimental data[J].Biomedicine & Pharmacotherapy,1989,(04):251-260.
  • 4Pendyala L,Creaven PJ. In vitro cytotoxicity,protein binding,red blood cell partitioning,and biotransformation of oxaliplatin[J].Cancer Research,1993,(24):5970-5976.
  • 5Extra JM,Espie M,Calvo F. Phase Ⅰ study of oxaliplatin in patients with advanced cancer[J].Cancer Chemotherapy and Pharmacology,1990,(04):299-303.
  • 6Hussain S,Pluckthun A,Allen TM. Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system[J].Molecular Cancer Therapeutics,2007,(11):3019-3027.
  • 7Allen TM,Hansen C,Martin F. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol)show prolonged circulation half-lives in vivo[J].Biochimica et Biophysica Acta,1991,(01):29-36.
  • 8Ishida O,Maruyama K,Sasaki K. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice[J].International Journal of Pharmaceutics,1999,(01):49-56.
  • 9Szoka F Jr,Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation[J].Proceedings of the National Academy of Sciences of the United States of America,1978,(09):4194-4198.
  • 10Ishii F,Nagasaka Y. Simple and convenient method for estimation marker entrapped in liposomes[J].Journal of Dispersion Science and Technology,2001,(01):97-101.

同被引文献59

  • 1胡玉佳,张忠义,李红磊,张守尧.丹参酮传递体的制备及其变形性[J].南方医科大学学报,2006,26(3):297-300. 被引量:6
  • 2杨清娥,张宏利,韩崇选,杨学军,王明春.氧化槐果碱的提取分离工艺及其毒性研究[J].西北林学院学报,2006,21(3):111-113. 被引量:16
  • 3范荣,梁清华,王娟,唐涛,熊新贵,陈疆.柔性纳米脂质体载体增强双氯芬酸钠的经皮渗透效果:与普通外用制剂比较的随机对照动物实验[J].中国组织工程研究与临床康复,2007,11(18):3597-3600. 被引量:5
  • 4ThambTi,ParkJH.RecentAdvancesinShell-SheddableNanopar-ticlesforCancerTherapy[J].JournalofBiomedicalNanotechnol-ogy,2014,10(9):1-22.
  • 5AkbarzadehA,Rezaei-SadabadyR,DavaranS,etal.Liposome:classification,preparation,andapplications[J].NanoscaleResLett,2013,8(1):102-111.
  • 6KraftJC,FreelingJP,WangZ,etal.EmergingResearchandClini-calDevelopmentTrendsofLiposomeandLipidNanoparticleDrugDeliverySystems[J].JPharmSci,2014,103(1):29-52.
  • 7PiJ,LiuZ,ShuL,etal.TissuedistributionstudyofsalvianolicacidBlong-circulatingliposomesinmicebyUPLC-MS/MSdeter-mination[J].PakJPharmSci,2015,28(1):213-220.
  • 8ShaviGV,ReddyMS,RaqhavendraR,etal.PEGylatedliposomesofanastrozoleforlong-termtreatmentofbreastcancer:invitroandinvivoevaluation[J].JLiposomeRes,2015[Epubaheadofprint].
  • 9ZhouJ,ZhaoWY,MaX,etal.Theanticancerefficacyofpaclitaxelliposomesmodifiedwithmitochondrialtargetingconjugateinresist-antlungcancer[J].Biomaterials,2013,34(14):3626-3638.
  • 10AbuLilaAS,NawataK,ShimizuT,etal.Useofpolyglycerol(PG),insteadofpolyethyleneglycol(PEG),preventsinductionoftheacceleratedbloodclearancephenomenonagainstlong-circu-latingliposomesuponrepeatedadministration[J].IntJPharm,2013,456(1):235-242.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部